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Both riboflavin and vitamin B,, have in common a I ,2-dimethyl-4,5-diaminobenzene 
moiety (substance I), which could well be a biogenetic precursor of these two vitamins. 
Although substance I has not been demonstrated to be in the pathway for the bio- 
synthesis of these vitamins, a considerable amount of evidence is available in favour of 
such a view. 
\, 
Substance I, 1,z-dimethyl-4,5-diaminobenzene 
In  micro-organisms, substance I exhibited some small degree of riboflavin activity 
for Lactobacillus casei and also had some vitamin B,, potency for Euglena gran'lis, as 
well as for some other organisms requiring vitamin B,, (Woolley, 1950, 1951). Addi- 
tion of substance I to cultures of Bacillus megatherium stimulated vitamin B,, synthesis 
(Woolley, 1950). The precursor activity of substance I has been further suggested by 
the observation that an analogue, I ,2-dichloro-4,5-diaminobenzene, competitively 
inhibited synthesis by B. megatherium of riboflavin and vitamin B,, from substance I 
(Woolley, 1950). Addition of cobalt, which would normally stimulate synthesis of 
vitamin B,, by B. megatherium, with this analogue was found to aggravate the in- 
hibition of the synthesis (Woolley, 1950). Addition of substance I, or of the substances 
that closely resemble it, 5,6-dimethylbenziminazole and o-phenylenediamine, is known 
to stimulate synthesis of vitamin B,, by Streptomyces olivaceous (Ganguly & Roy, 1956) 
and by Streptomyces griseus (Dulaney & Williams, 1953). Riboflavin and 5,6- 
dimethylbenziminazole have been shown to cause a small but significant increase 
in synthesis of vitamin B,, by Escherichia coli (cf. Ford & Hutner, 1955). 
Added support for the view that biosynthesis of riboflavin and vitamin B,, may 
involve a common precursor is provided by observations that in media supplemented 
with cobalt there is an increased synthesis of riboflavin by Ashbya gossypii (Hickey, 
I 954), and that flavinogenesis by various micro-organisms synthesizing riboflavin was 
stimulated by additions of certain purines and amino acids (Ford & Hutner, 1955). 
Since single-carbon fragments may take part in the biosynthesis of riboflavin much in 
VOl. I 3  Ribojlavin-vitamin B,, interrelationships 469 
the same way as in the synthesis of purines and pyrimidines, this consideration may be 
taken to provide presumptive evidence that vitamin B,, can participate in the synthesis 
and mobilization of C, fragments (Ford & Hutner, 1955). It may also help in explaining 
why synthesis of riboflavin by A. gossypii (Smiley, Sobolov, Austin, Rasmussen, Smith, 
Van Lanen, Stone & Boruff, 1951) and by Eremothecium ashbyii (W. V. Lavate, 
unpublished) is invariably accompanied by synthesis of small but significant amounts 
of vitamin B,,-active compounds. 
In  animals, Emerson, Brink, Holly, Koniuszy, Hey1 & Folkers (1950) observed that 
substance I and 5,6-dimethylbenziminazole showed vitamin B,, activity when admini- 
stered to rats maintained on a diet devoid of animal-protein products and containing 
thyroid powder, but that these two compounds were required for the purpose in 
larger amounts than vitamin B,,. It was observed further (Emerson, Holly, Shunk, 
Brink & Folkers, 195 I) that a higher derivative, a-ribazole (r-a-~-ribofuranoside-5,6- 
dimethylbenziminazole), exhibited vitamin B,, activity of the same order as vitamin 
B,, itself. However, a riboflavin-like derivative, 1-~-ribityl-5,6-dimethylbenzimin- 
azole, possessed much less vitamin B,, activity. Similar results were reported by 
Cooperman & Tabenkin (1951) with riboflavin, and some of the above compounds 
tested orally or by intraperitoneal injection. Hartman, Dryden & Cary (1949, 1951) 
noted that large amounts of dietary riboflavin may promote intestinal synthesis of 
vitamin B,, in rats. 
Pronounced lowering of the concentration of vitamin B,, in liver, kidney and heart 
has been observed in riboflavin deficiency (Bhagwat & Sohonie, 1954, 1955). Similarly, 
diminution in the riboflavin content of the liver (Bhagwat & Sohonie, 1955) and decrease 
in activities of some liver dehydrogenases (Bhagwat & Sohonie, 1955 ; Murthy, 
Desikachar & Swaminathan, 1956 ; Williams, Monson, Sreenivasan, Dietrich, Harper & 
Elvehjem, 1953) have been reported in vitamin B,, deficiency. 
This survey of the available information on the interrelation of riboflavin and 
vitamin B,, would seem to indicate that in micro-organisms there is good evidence 
that riboflavin and vitamin B,, may have common biogenetic pathways. However, 
for animals, information about the extent and nature of this interrelationship is not 
adequate, and the position is complicated by microbial activities in the intestinal tract. 
I n  this paper, some experiments are described with rats rendered deficient in either 
of these vitamins. 
EXPERIMENTAL 
Animals and management 
Experiment I. Twenty-four weanling rats (Wistar strain) of both sexes were reared 
for 4 weeks on a basal diet free from riboflavin and vitamin B,, of the percentage 
composition: ethanol-extracted casein 18, maize starch 60, vitaminized sucrose I I, 
vitaminized sesame oil 7, and salt mixture (U.S. Pharmacopoeia, XIV, 1950) 4. Vitamins 
A, D and E (a-tocopherol) were provided with the sesame oil and the others with the 
sucrose. The amounts of vitamins supplied per kg diet were: thiamine hydrochloride 
6 mg, nicotinic acid 30 mg, calcium pantothenate 20 mg, pyridoxine hydrochloride 
6 mg, folic acid 5 mg, biotin I mg, p-aminobenzoic acid IOO mg, choline chloride 
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500 mg, inositol 500 mg, menaphthone 10 mg, vitamin A 5000 i.u., vitamin D 50 i.u. 
and a-tocopherol jo mg. 
At the end of this initial depletion period, growth had ceased almost completely and 
other characteristic signs of riboflavin deficiency had appeared. At this stage, the 
animals were divided into four similar groups. One group continued to receive the 
basal diet, and the remaining three were placed on the basal diet supplemented with 
200pglkg vitamin B,, or 10 mg/kg riboflavin or both. 
The animals were fed ad lib. for 4 weeks, and their weight was recorded at weekly 
intervals. All the animals were then killed under ether anaesthesia, to obtain samples 
of blood and liver. Blood drawn from the hepatic portal vein was immediately citrated. 
The livers were chilled and made into 20 yo homogenates with ice-cold distilled water 
in a Potter-Elvehjem glass homogenizer. 
Experiment 2. Twenty-four animals were reared during the pre-experimental period 
of 4 weeks on the basal diet supplemented with 0.15 % iodinated casein (Protomone, 
Cerophyl Laboratories, Kansas City, Mo., U.S.A.) to accelerate the depletion of 
vitamin B,, reserves. The various experimental diets given for the next 4 weeks did 
not contain iodinated casein, but included 1.5 yo succinylsulphathiazole to suppress 
intestinal synthesis. The basal diet, grouping of animals and the experimental diets 
were otherwise the same as in Expt I. 
This procedure for induction and maintenance of vitamin B,, deficiency was not 
attended by complications such as are likely to result from prolonged administration 
of diets with iodinated protein (cf. Fatterpaker, Lavate, Mulgaonkar, Noronha, Rege, 
Tipnis & Sreenivasan, 19 59). The vitamin supplements provided were adequate to 
meet the needs of the animals (cf. Ershoff, 1948). 
Analytical methods 
Vitamin B,, was liberated from liver and blood by treatment with papain (British 
Drug Houses Ltd), and was assayed in liver samples with E.  gracilis (Hoff-J~rgensen, 
1954) and in blood samples with Lactobacillus leichmannii A.T.C.C. 7830 by a turbi- 
dimetric modification of the U.S.P. method (Rege, 1953). Flavinadenine dinucleotide 
(FAD) and total riboflavin in liver were determined fluorimetrically by the procedure 
of Bessey, Lowry & Love (1949). 
Xanthine-oxidase activity of. liver was estimated manometrically by the method of 
Dhungat & Sreenivasan (1954). 
T o  determine total protein in liver, 2. j ml of the 20 yo homogenate (equivalent to 
500 mg of fresh tissue) was taken in a tared centrifuge tube to which 7 ml of a 10% 
(w/v) solution of trichloroacetic acid were added. The tissue was well dispersed in the 
trichloroacetic-acid solution with a glass rod, centrifuged and the supernatant liquid 
was poured off. The treatment with trichloroacetic acid was repeated twice and was then 
followed once by treatment with j ml of 95 % ethanol, two further treatments with 
j ml portions of a 3 : I mixture of 9 j yo ethanol and diethyl ether, and a final treatment 
with 5 ml of diethyl ether. The residue was thoroughly mixed every time and centri- 
fuged for 10 min at 8oog. The residue left finally in the centrifuge tube was dried at 
80" for about 18 h and weighed to give the weight of protein. 
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It was observed that the results obtained by this procedure agreed well with those 
obtained by the Kjeldahl method, as has also been reported by Osborn, Felts & 
Chaikoff (1953) with a similar procedure. 
Table I .  Expt I. Effect on rats depleted of ribojlavin and vitamin B,, of a diet free from 
both vitamins or supplemented with one or with both 
(Mean values with their standard errors; six animals/group) 
Weight 
gain in 
4 weeks 
Basal* 1yof5'o 
Basal+vitamin Bllt I 8.0 f 6.0 
Basalfriboflavinr 110'0 f 10'0 
Basal+vitamin B,.t+riboflavint. 125.0 f 10.0 
Diet (9) 
Vitamin BI2 Liver Total 
,-J-\ flavinadenine liver 
Blood Liver dinucleotide riboflavin 
(mfig/ml) (mwltd (@gig) (@gig) 
1 '30i0 .15  56.0f3.o 6.4fo.30 8 . z i o . z o  
I ' Z O ~ O ' I O  75'0f3'5 6.1 i 0 . 2 5  9'8fo .35  
1'35i.o.10 8z.oj:q'o 1 7 7 i 0 . 7 5  31.oj:1.50 
1 '45io .15  9 3 ' 0 f 4 5  zo ' r io .90  30'0f1%?0 
Liver 
xanthine- 
oxidase Total liver 
activity protein 
(PI Oi/h/g) (g/IOo g) 
1 1 1 . 5 i 1 8 . 5  1 4 8 f 0 . 5  
1 1 2 ~ 0 f 2 2 ' 5  15'3*0.7 
250'0 k 12.5 17'1 f0 .9  
279'0&10'0 17'4fo.6 
* Free from riboflavin and vitamin BIZ. t zoo@g/kg. 1 10 mg/kg. 
RESULTS 
The results of the first experiment are reported in Table I .  It may be seen that severe 
riboflavin deficiency was produced in animals reared on diets devoid of this vitamin. 
The  rats grew little during the 4 weeks and had considerably less FAD, total riboflavin 
and xanthine oxidase in their livers than the controls. However, animals on the diets 
free from vitamin B,, did not develop appreciable deficiency, and it appeared that 
considerable intestinal synthesis of vitamin B,, had occurred. Since the production 
of vitamin B,, deficiency was not satisfactory in this experiment, not much could be 
ascertained about the effects of associated deficiencies of these two vitamins. 
The results of the second experiment are summarized in Table 2. The values for 
liver vitamin B,, in the animals on the diets free from vitamin B,, show that a satis- 
factory deficiency was produced. The manifestations of riboflavin deficiency were 
almost the same as in Expt I .  
Table 2. Expt 2. Effect on rats depleted of ribojlavin and vitamin B,, of a diet con- 
taining 1-5 yo succinylsulphathiazole and free from both vitamins or supplemented with 
one or with both 
(Mean values with their standard errors; six animals/group) 
Weight 
gain in 
4 weeks 
Diet (9) 
Basal* 14'0 k6.0 
Basal+vitamin Bllt 1 6 . 0 i 4 ' 0  
Basali-vitamin BlSt+riboflavinI 108.0 i 12.0 
Basal+riboflavinr 95'0 15'0 
Vitamin BIZ Liver Total 
<-*--\ flavinadenine liver 
Blood Liver dinucleotide riboflavin 
( m d m l )  (mpdg) ( Pg/d ( m/g) 
1 ' 1 5 i 0 . 2 5  45'0f3'0 7 '3 fo .50  11'1 iO'4O 
1.00 iozzo 82.0 f 7 . 0  7.7 j:0.80 12.0 f 0 6 0  
1'40 10.30 108.0 i 8 . 0  20.2 h0.85 29'5 io'50 
1 '55*0 '15  42'0f5'0 1 5 ' 5 f 0 ' 5 0  2 8 . Z f O . 8 0  
Liver 
xanthine- 
oxidase 
activity 
( P I  Oi/h/g) 
162.5 542.5 
152'5 fso 'o  
360.5 i-49.5 
277'5 h40.0 
Total 
liver 
protein 
(gl100 8) 
12.9 j: 1.0 
13'5 k0.8 
1 6 . 4 i 0 . 4  
16.0 i0.7 
* Free from riboflavin and vitamin B,*. t zoo pg/kg. 1 10 mgjkg. 
There was some mortality in riboflavin-deficient animals in both experiments, due 
to the severity of the deficiency. Depression of growth was not alleviated to any 
significant extent by administration of vitamin B12. Though full growth occurred only 
when both riboflavin and vitamin B,, were present, deficiency of vitamin B,, alone 
caused only a slight retardation of growth. 
In  a combined deficiency of riboflavin and vitamin B,,, growth retardation and 
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decreases in liver contents of total protein, xanthine oxidase, FAD, non-FAD and total 
riboflavin, and vitamin B,, as well as in blood vitamin B,, were, in general, more pro- 
nounced than those in the single deficiency of either vitamin. 
Addition of vitamin B,, to the basal diet improved the liver vitamin B,, level, but 
caused no significant alterations in blood vitamin B,, or in other liver constituents. 
DISCUSSION 
In  groups on diets adequate in vitamin B,,, liver levels of this vitamin were influenced 
by the intake of riboflavin, which suggests that lack of riboflavin adversely affected the 
metabolism and storage in liver of vitamin B,,. 
With a deficiency of vitamin B,, alone, the levels of liver protein and riboflavin were 
nearly normal. However, the contents of liver FAD and of its xanthine-oxidase 
activity were only partly restored. A non-specific decrease in the xanthine-oxidase 
activity of the liver in vitamin B,,-deficient rats has also been reported by Williams 
et al. (1953). This observation appears to be of interest, since it points to a probable 
function of vitamin B,, in the biosynthesis of FAD from non-FAD riboflavin. I n  rat 
liver, FAD synthesis from riboflavin occurs as follows (Schneider, 1955) : 
Riboflavin + adenosine triphosphate (ATP) -+ flavinadenine mononucleotide (FMN) 
+ adenosine diphosphate 
FMN + ATP -+ FAD + pyrophosphate. 
The site of synthesis is exclusively the soluble fraction of liver, and the FAD thus 
synthesized is to a large extent (up to 65 %) stored in mitochondria (Schneider, 1955). 
Other observations (unpublished observations of U. Marfatia, H. P. Tipnis, D. V. 
Rege and A. Sreenivasan in this laboratory) have shown that the decrease in liver 
content of FAD in vitamin B,, deficiency is paralleled by a decrease in mitochondrial 
content; this work has also shown that the conversion in vivo of administered ribo- 
flavin into FAD is impaired by a deficiency of vitamin B,,, and is restored to normal 
by supplementation with the vitamin. A protection exerted by prior administration 
of vitamin B,, against certain metabolic derangements in the rat caused by experimental 
thyrotoxicosis or liver injury was reported by Kasbekar, Lavate, Rege & Sreenivasan 
(1959a, b). This protection was evidenced primarily by reduction in the losses of 
intramitochondrial components including nucleotides, vitamin B,, and glutathione 
(Kasbekar & Sreenivasan, 1956; Kasbekar, Rege & Sreenivasan, 1959), which occur 
under the conditions of stress studied. It seems likely, therefore, that the decreased 
synthesis of FAD in vitamin B,, deficiency may be accompanied by a release of intra- 
mitochondrial FAD. However, further work is necessary to ascertain the specificity 
of such relationships of various stress or deficiency states to the changes, qualitative 
and quantitative, in cell components. 
In  animals deficient only in vitamin B,, (Expt I), considerable increase in liver 
vitamin B,, occurred, even though the vitamin was absent from the diet. When a sulpha 
drug was present in the same diet (as in Expt 2) no such increase in the liver vitamin 
B,, was observed. Since the diets were adequate in riboflavin, these results suggest 
that, in the absence of the sulpha drug, dietary riboflavin could induce profuse 
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synthesis of vitamin B,, in the intestine, a part, at least, being absorbed by the host 
animal. The observations support the conclusion of Hartman et al. (1949, 1951) that 
dietary riboflavin induces intestinal synthesis of vitamin B,,-active materials. Their 
conclusion was, however, based only on observations on growth. 
In  uncomplicated riboflavin deficiency, dietary vitamin B,, was not effective in 
improving the riboflavin status of the animals, which indicates that dietary vitamin 
B,, does not support intestinal synthesis of riboflavin or that such synthesis is in- 
adequate. Thus, liver levels of FAD and riboflavin of animals deficient only in ribo- 
flavin were not different from those of the group deficient in both riboflavin and 
vitamin B,,, and were considerably lower than those of animals receiving riboflavin 
alone or together with vitamin B,,. 
The activity of riboflavin in promoting intestinal synthesis of vitamin B,, need not 
necessarily imply that the vitamin is actually broken down to provide a nucleotide 
precursor of the vitamin B,, molecule. An alternative explanation could be that a 
common precursor of riboflavin and vitamin B,, is normally available in limiting 
amounts, and is used preferentially for the synthesis of riboflavin. The  provision of 
preformed riboflavin might then spare such a precursor for the synthesis of vitamin 
B,, (Ford & Hutner, 1955). This suggestion may also explain why vitamin B,, is not 
broken down in the intestine to provide the benziminazole moiety for riboflavin 
synthesis. 
SUMMARY 
I. Twenty-four weanling rats were fed for 4 weeks on a diet free from riboflavin 
and vitamin B,,. They were then divided into four groups; one received for the next 
4 weeks the basal diet alone and the other three the basal diet supplemented with 
zoopg vitamin B,,/kg or 10 mg riboflavin/kg or both. A second lot of twenty-four 
weanling rats was treated in the same way except that the diet given in the first 4 weeks 
was supplemented with 0.15 yo iodinated casein and each experimental diet with 1-5 yo 
succinylsulphathiazole. 
2. The effects of deficiencies of riboflavin and vitamin B,, on the liver storage of 
these two vitamins were studied. The protein content and xanthine-oxidase activity 
of the liver were also examined. In  addition, the influence of the intestinal microflora 
upon these changes was investigated. 
3. In  the riboflavin-deficient rats there was a pronounced fall in the liver content 
of vitamin B,, and protein. In  vitamin B,,-deficient rats, the flavinadenine-di- 
nucleotide content and xanthine-oxidase activity, but not the total riboflavin content, 
of the liver were decreased. 
4. Dietary riboflavin appeared to induce profuse intestinal synthesis of vitamin B,,, 
which was checked by addition of succinylsulphathiazole to the diet. Dietary vitamin B,, 
apparently did not stimulate intestinal synthesis of riboflavin, but appeared to influence 
in some way the biosynthesis of FAD from non-FAD riboflavin in animal tissues. 
One of us (W.V.L.) wishes to thank the Ministry of Education, Government of 
India, for a research fellowship, during the tenure of which this work was carried out. 
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